Sign up for free insights newsletter

JNJ vs MRK: Johnson & Johnson vs Merck & Company Inc

Side-by-side comparison of key financial metrics, valuation ratios, profitability, growth, and risk-adjusted returns. Both companies are in the Healthcare sector. Both are listed in United States.

Johnson & Johnson
JNJUnited States
$224.26
+1.28%
United States
$532.77B
Merck & Company Inc
MRKUnited States
$112.37
+0.98%
United States
$275.09B

Quick Summary

Johnson & Johnson is 1.9× the market cap of Merck & Company Inc. JNJ trades at a lower P/E than MRK. MRK offers the higher dividend yield.

Price & Performance

MetricJNJMRK
Current Price$224.26$112.37
Daily Change1.28%0.98%
1-Year Return51.08%46.64%
52-Week High$248.56$123.93
52-Week Low$146.36$73.47
50-Day MA$236.41$116.57
200-Day MA$207.72$100.68
Beta0.260.20

Size & Revenue

MetricJNJMRK
Market Cap$532.77B$275.09B
Enterprise Value$565.70B$318.50B
Revenue (TTM)$96.36B$65.77B
Shares Outstanding2.41B2.47B
Float2.40B2.47B
Employees138,20073,000

Valuation

MetricJNJMRK
Trailing P/E25.6531.37
Forward P/E19.1222.03
PEG Ratio2.885.18
Price / Sales5.534.18
Price / Book6.566.00
EV / EBITDA16.7816.41

Profitability

MetricJNJMRK
Profit Margin21.83%13.59%
Operating Margin (TTM)27.41%38.60%
Return on Equity26.42%18.94%
Return on Assets8.42%12.58%
Diluted EPS (TTM)8.633.55

Growth

MetricJNJMRK
Revenue Growth (YoY)9.90%4.90%
Earnings Growth (YoY)-52.90%-19.30%

Dividends

MetricJNJMRK
Dividend Yield2.34%2.92%
Dividend / Share5.203.28

Risk-Adjusted Returns & Quality

MetricJNJMRK
Sortino (Composite)1.631.00
Sharpe (Composite)0.850.56
Calmar (Composite)0.730.11
Hurst Exponent0.56450.5621
Piotroski F-Score7/95/9

Ownership

MetricJNJMRK
% Insiders6.10%6.50%
% Institutions7632.80%8391.60%
Green highlighting indicates the more favorable value for each metric. Data is for informational purposes only and may be delayed.